Aug 06, 2014 7:00am EDT New Data Shows High Efficacy for Can-Fite's CF101 in Rheumatoid Arthritis and Psoriasis Patients
Jul 21, 2014 7:00am EDT Can-Fite CEO to Deliver Scientific Presentation and Serve on Expert Panel at Purines 2014 in Bonn, Germany on July 23-27, 2014
Jul 10, 2014 7:00am EDT Can-Fite's CF102 Approved for Compassionate Use in Israel for Liver Cancer Patient
Jun 19, 2014 7:00am EDT Can-Fite to Exhibit at Bio International Convention in San Diego on June 23 - 26, 2014
Jun 17, 2014 7:00am EDT Can-Fite Completes Patient Enrollment in its Phase II/III Psoriasis Trial; Final Results are expected in Q1 2015
Jun 10, 2014 7:00am EDT Can-Fite to Participate in Newport Coast Securities Conference in New York & ROTH Conference in London
Jun 09, 2014 7:00am EDT Can-Fite Subsidiary OphthaliX Provides an Update on its Clinical Developments and Strategic Plans
Jun 02, 2014 7:00am EDT Can-Fite Announces that the US FDA has Agreed with its Phase II Liver Cancer Protocol
